EXPONENTIAL INNOVATION.

We are a driving force behind medical innovation,
serving as an incubator for ideas and a catalyst for change.

 
Spiral Background Small.png
 
 
 

It takes grit, vision and an innate resilience to brave the ideation process and build a roadmap to commercialization. Due to current systems unique to the life sciences, the process is incredibly complex, costly and time-intensive. This creates a huge barrier to entry into an industry that is not only ripe for innovation but also impacts lives around the world. To overcome the monumental barrier, accelerate innovation, and impact lives around the world, IntuitiveX was born.

 
 

services

 
 

From initial concept to final commercialization, we have the in-house knowledge and network of resources to meet your unique needs.

 
 

incubation


Our closed loop incubation model allows for unparalleled collaboration through all stages, including product development, prototyping, FDA, FTC, legal compliance, and more.

 

consultation


As subject-matter experts in the life sciences domain, our team provides data-driven insights and guidance where needed, from IP prototyping to capital fundraising, and beyond.

 

investment


With a portfolio spanning from spinal implant devices to AI/ML, the opportunity to diversify investment is simple. Investors have exclusive access to our portfolio companies with a unique opportunity to invest in them first.

 

 OUR PORTFOLIO

 
Aevitas Spine Name Text.png
 

Thru-Fuze Spinal Fusion Device


 
altpep.jpg
 

altpep

A revolutionary platform for tackling amyloid diseases:
early diagnostics, disease-modifying therapeutics, and anti-biofilm treatments


 

AltPep improves human health by identifying the toxic structures that cause amyloid diseases and developing proprietary synthetic peptides to neutralize those structures. AltPep has developed a library of novel synthetic peptides. This library functions as an arsenal designed to target, and attack, the root cause of amyloid diseases at the molecular level.

AltPep’s patented technology provides a groundbreaking platform for targeting amyloid diseases and improving human health.

Initial AltPep targets:

  • Anti-biofilm therapies and coatings

  • Early diagnostic for Alzheimer’s Disease (AD)

  • Disease-modifying therapeutics for Alzheimer's Disease

 

 
 
 

Minimally invasive, endoscopic surgical solutions.

 

 
auctus_surgical.png
 

Dynamic spinal tethering system


CHIRAL SURGICAL

 
 

Sinistrality in surgery


 
Slide1.jpg
 
 

A smart, wearable solution providing on-the-go monitoring and treatment for DVT patients

 

 
 

Simplifying and modernizing the process of tooth preparation


 
 

TULIF surgical approach to eliminating visible scarring


 
Precisive Deck (3).jpg
 

AI platform to enhance surgical navigation


 
Protogenyx Text.png
 

Additive manufacturing and 3D printing for the masses